Denise Mafra

8.3k total citations
253 papers, 5.9k citations indexed

About

Denise Mafra is a scholar working on Nephrology, Molecular Biology and Physiology. According to data from OpenAlex, Denise Mafra has authored 253 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Nephrology, 83 papers in Molecular Biology and 79 papers in Physiology. Recurrent topics in Denise Mafra's work include Dialysis and Renal Disease Management (80 papers), Diet and metabolism studies (40 papers) and Gut microbiota and health (39 papers). Denise Mafra is often cited by papers focused on Dialysis and Renal Disease Management (80 papers), Diet and metabolism studies (40 papers) and Gut microbiota and health (39 papers). Denise Mafra collaborates with scholars based in Brazil, France and Sweden. Denise Mafra's co-authors include Denis Fouque, Milena Barcza Stockler‐Pinto, Viviane de Oliveira Leal, L. Cardozo, Natália Alvarenga Borges, Peter Stenvinkel, Bengt Lindholm, Maurilo Leite, Lívia Alvarenga and Sílvia Maria Franciscato Cozzolino and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemistry and Scientific Reports.

In The Last Decade

Denise Mafra

237 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denise Mafra Brazil 44 2.0k 1.9k 1.9k 1.1k 591 253 5.9k
Harold A. Franch United States 25 2.4k 1.2× 843 0.4× 2.2k 1.2× 1.1k 1.0× 798 1.4× 47 6.6k
Thao Nguyen‐Khoa France 33 2.0k 1.0× 903 0.5× 691 0.4× 757 0.7× 689 1.2× 84 5.4k
Tomáš Zima Czechia 41 873 0.4× 1.4k 0.7× 698 0.4× 575 0.5× 649 1.1× 357 6.5k
Lynda Frassetto United States 37 1.8k 0.9× 849 0.5× 1.4k 0.7× 477 0.5× 566 1.0× 108 4.8k
Griet Glorieux Belgium 48 5.1k 2.6× 2.3k 1.2× 1.5k 0.8× 443 0.4× 1.2k 2.1× 183 8.3k
Robert G. Fassett Australia 34 1.4k 0.7× 1.1k 0.6× 641 0.3× 422 0.4× 721 1.2× 140 4.6k
Jean‐Paul Cristol France 56 2.3k 1.2× 2.7k 1.4× 2.1k 1.1× 1.3k 1.2× 1.9k 3.3× 427 12.6k
Chih‐Kang Chiang Taiwan 42 1.5k 0.8× 1.2k 0.6× 617 0.3× 187 0.2× 551 0.9× 177 5.0k
Hamid Nasri Iran 38 952 0.5× 1.0k 0.6× 434 0.2× 615 0.6× 654 1.1× 350 6.1k
Nicola Di Daniele Italy 40 483 0.2× 1.1k 0.6× 1.5k 0.8× 416 0.4× 564 1.0× 193 5.1k

Countries citing papers authored by Denise Mafra

Since Specialization
Citations

This map shows the geographic impact of Denise Mafra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise Mafra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise Mafra more than expected).

Fields of papers citing papers by Denise Mafra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise Mafra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise Mafra. The network helps show where Denise Mafra may publish in the future.

Co-authorship network of co-authors of Denise Mafra

This figure shows the co-authorship network connecting the top 25 collaborators of Denise Mafra. A scholar is included among the top collaborators of Denise Mafra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise Mafra. Denise Mafra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alvarenga, Lívia, L. Cardozo, Bruna R. Paiva, et al.. (2025). Effects of Tocotrienol on Cardiovascular Risk Markers in Patients With Chronic Kidney Disease: A Randomized Controlled Trial. Journal of Nutrition and Metabolism. 2025(1). 8482883–8482883. 1 indexed citations
2.
Mafra, Denise, et al.. (2025). Low‐protein diet for chronic kidney disease: Evidence, controversies, and practical guidelines. Journal of Internal Medicine. 298(4). 319–335. 1 indexed citations
3.
Kemp, Julie Ann, Márcia Ribeiro, Natália Alvarenga Borges, et al.. (2025). Dietary Intake and Gut Microbiome in CKD. Clinical Journal of the American Society of Nephrology. 20(7). 1003–1013. 3 indexed citations
4.
Alvarenga, Lívia, et al.. (2025). Bioactive Compounds as Modulators of N-Formyl Peptide Signaling in Chronic Diseases. Molecules. 30(14). 2981–2981.
5.
Ribeiro‐Alves, Marcelo, et al.. (2025). Trimethylamine N‐Oxide Plasma Levels Following Red Meat and Cod Fish Intake: A Pilot Crossover Trial in Hemodialysis Patients. Molecular Nutrition & Food Research. 69(8). e70031–e70031. 1 indexed citations
6.
Mafra, Denise, et al.. (2024). Is the enteric nervous system a lost piece of the gut-kidney axis puzzle linked to chronic kidney disease?. Life Sciences. 351. 122793–122793. 3 indexed citations
7.
Ribeiro, Márcia, L. Cardozo, Bruna R. Paiva, et al.. (2024). Zinc status and inflammation in patients on hemodialysis: a cross-sectional observational study. Nutrire. 49(2). 1 indexed citations
8.
Cardozo, L., Lívia Alvarenga, Jessyca Sousa de Brito, et al.. (2024). Effects of Cranberry Extract (Vaccinium macrocarpon) Supplementation on Lipid Peroxidation and Inflammation in Patients with Chronic Kidney Disease (Stages 3-4): A Randomized Controlled Trial. Journal of Nutrition and Metabolism. 2024. 1–11. 2 indexed citations
9.
Alvarenga, Lívia, L. Cardozo, Bruna R. Paiva, et al.. (2023). Can curcumin supplementation break the vicious cycle of inflammation, oxidative stress, and uremia in patients undergoing peritoneal dialysis?. Clinical Nutrition ESPEN. 59. 96–106. 15 indexed citations
10.
Dai, Lu, Denise Mafra, Paul G. Shiels, et al.. (2023). Vitamin K and Hallmarks of Ageing: Focus on Diet and Gut Microbiome. Nutrients. 15(12). 2727–2727. 18 indexed citations
11.
Alvarenga, Lívia, L. Cardozo, Marcelo Ribeiro‐Alves, et al.. (2023). Effects of turmeric extract supplementation on the lipid and lipoprotein subfraction profile in hemodialysis patients: A randomised, double‐blind, crossover and controlled trial. Phytotherapy Research. 37(8). 3424–3437. 8 indexed citations
12.
13.
Borges, Natália Alvarenga, Bruna R. Paiva, Lívia Alvarenga, et al.. (2021). Effect of cranberry supplementation on toxins produced by the gut microbiota in chronic kidney disease patients: A pilot randomized placebo-controlled trial. Clinical Nutrition ESPEN. 47. 63–69. 17 indexed citations
14.
Brito, Jessyca Sousa de, Natália Alvarenga Borges, Lia S. Nakao, et al.. (2019). Aryl Hydrocarbon Receptor and Uremic Toxins from the Gut Microbiota in Chronic Kidney Disease Patients: Is There a Relationship between Them?. Biochemistry. 58(15). 2054–2060. 26 indexed citations
15.
Mafra, Denise, Natália Alvarenga Borges, D’Angelo Carlo Magliano, et al.. (2018). Bioactive food and exercise in chronic kidney disease: Targeting the mitochondria. European Journal of Clinical Investigation. 48(11). e13020–e13020. 21 indexed citations
16.
Leal, Viviane de Oliveira, Cristiane Moraes, Milena Barcza Stockler‐Pinto, et al.. (2012). Is a body mass index of 23 kg/m2 a reliable marker of protein–energy wasting in hemodialysis patients?. Nutrition. 28(10). 973–977. 25 indexed citations
17.
Mafra, Denise & Najla Elias Farage. (2006). O papel do tecido adiposo na doença renal crônica. 28(2). 108–113. 4 indexed citations
18.
Bastos, Marcus Gomes, et al.. (2004). Doença Renal Crônica: Problemas e Soluções. 26(4). 202–215. 32 indexed citations
19.
Mafra, Denise. (2003). Minerais e doença renal crônica. 25(1). 17–24. 1 indexed citations
20.
Mafra, Denise. (2003). Minerals and chronic renal disease. 25(1). 17–24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026